Based on the company's latest reports for September 2025, the current 12-month EPS is $10.91. Waters's earnings per share in 2024 was reported at $10.75, marking a decline from $10.87 in 2023. In the quarterly report ending on Sep 27, 2025, WAT's earnings per share amounted to $2.5.
Waters had an yealy earnings per share of $10.75, showing a decline of 1.1% from $10.87 recorded in 2023. The quarterly earnings per share for the period ending Sep 27, 2025, was $2.5, showing a 8.1% decline compared to the same quarter last year. The trailing twelve months EPS for WAT is $10.91 as of September 2025. Waters's full-year EPS for 2023 was $10.87, a 7.9% decline compared to the previous year.
Waters has recorded a decline in earnings per share of 8.1% in the past 12 months (YoY, quarterly). During the past three years, WAT registered an average yearly EPS growth of -1.5%. Waters had an average annual EPS growth of 4.2% in the last five years. Over the last decade, WAT had an average annual earnings per share growth of 7.7%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| TMO Thermo Fisher Scientific Inc | 32.74 | 6.8% | -5.5% | 12.4% |
| WAT Waters Corp | 34.09 | -1.1% | -1.5% | 4.2% |
| A Agilent Technologies Inc | 34.29 | 5.2% | 3.7% | 5.4% |
| MTD Mettler Toledo International Inc | 36.37 | 12.7% | 6.9% | 12.2% |
| GE General Electric Co | 40.36 | -28.4% | N/A | N/A |
| DHR Danaher Corp | 43.49 | -17.2% | -15.3% | 5.3% |
| BRKR Bruker Corp | 77.31 | -74% | -25.4% | -9.8% |
| BIO Bio-Rad Laboratories Inc | N/A | -199.5% | N/A | N/A |
| HBIO Harvard Bioscience Inc | N/A | -250% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.